ICF (NASDAQ:ICFI), a global consulting and digital services provider, was recently awarded a re-compete task order by the U.S. Centers for Disease Control and Prevention (CDC), Center for Surveillance, Epidemiology, and Laboratory Services (CSELS) to support multiple aspects of its BioSense program, CDC’s cloud-based public health surveillance system.
The task order, which was awarded by the Division of Health Informatics and Surveillance (DHIS), has a value of $20 million and a term of one base year and two options years.
Part of the national emergency preparedness system, the BioSense syndromic surveillance system increases the ability of local, state and national health officials to monitor and respond to the harmful health effects of exposure to disease, addiction and hazardous conditions.
“Over the past few years, ICF has helped CDC significantly increase the national coverage of data providers and the number of jurisdictions and users that are supported by BioSense,” said Terence McKittrick, senior vice president for ICF. “The BioSense system stores nearly 40 terabytes of data, information crucial to the surveillance of important health issues such as the nation’s opioid crisis. We look forward to working with CDC to continue to improve this critical public health information system.”
ICF will provide expertise and support services to BioSense in the areas of surveillance, information management, technology and data management and analytics. Specifically, the company will help CDC expand of the scale and scope of the platform by continuing to help improve the quality of its surveillance data, enhance the technology of the BioSense platform and expand its coverage to build nationwide situational awareness capabilities with federal, state and local partners.
Read more about ICF’s public health services including health informatics, data management and disease surveillance.
